279 related articles for article (PubMed ID: 6441303)
1. The diagnosis of lupus anticoagulants by the activated partial thromboplastin time--the central role of phosphatidyl serine.
Kelsey PR; Stevenson KJ; Poller L
Thromb Haemost; 1984 Oct; 52(2):172-5. PubMed ID: 6441303
[TBL] [Abstract][Full Text] [Related]
2. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
3. The dilute phospholipid APTT: a sensitive assay for verification of lupus anticoagulants.
Alving BM; Baldwin PE; Richards RL; Jackson BJ
Thromb Haemost; 1985 Oct; 54(3):709-12. PubMed ID: 3937268
[TBL] [Abstract][Full Text] [Related]
4. Similar mechanism of various lupus anticoagulants.
Exner T
Thromb Haemost; 1985 Feb; 53(1):15-8. PubMed ID: 3922078
[TBL] [Abstract][Full Text] [Related]
5. Lipid class composition and heparin sensitivity in the activated partial thromboplastin time.
Stevenson KJ; Easton AC; Thomson JM; Poller L
Thromb Haemost; 1983 Aug; 50(2):601-3. PubMed ID: 6636037
[TBL] [Abstract][Full Text] [Related]
6. The laboratory heterogeneity of lupus anticoagulants.
Triplett DA; Brandt JT; Maas RL
Arch Pathol Lab Med; 1985 Oct; 109(10):946-51. PubMed ID: 3929747
[TBL] [Abstract][Full Text] [Related]
7. The sensitivity of different coagulation reagents to the presence of lupus anticoagulants.
Brandt JT; Triplett DA; Musgrave K; Orr C
Arch Pathol Lab Med; 1987 Feb; 111(2):120-4. PubMed ID: 3101649
[TBL] [Abstract][Full Text] [Related]
8. [Regulation of coagulo-fibrinolytic activity and lupus anticoagulants in systemic lupus erythematosus].
Fusegawa H; Ichikawa Y; Tanaka Y; Shiba T; Kawada T; Shimizu H; Moriuchi J; Arimori S; Ando Y
Ryumachi; 1990 Apr; 30(2):90-8. PubMed ID: 2122531
[TBL] [Abstract][Full Text] [Related]
9. [Lupus anticoagulant screening: comparison of 5 tests (author's transl)].
Follea G; Ffrench P; Trzeciak MC; Dechavanne M
Nouv Rev Fr Hematol (1978); 1981; 23(4):203-7. PubMed ID: 7312614
[TBL] [Abstract][Full Text] [Related]
10. Two different incubation times for the activated partial thromboplastin time (APTT): a new criterion for diagnosis of lupus anticoagulant.
Robert A
Thromb Haemost; 1994 Feb; 71(2):220-4. PubMed ID: 8191402
[TBL] [Abstract][Full Text] [Related]
11. Effect of lupus anticoagulants on the activated partial thromboplastin time. Results of the College of American Pathologists survey program.
Brandt JT; Triplett DA; Rock WA; Bovill EG; Arkin CF
Arch Pathol Lab Med; 1991 Feb; 115(2):109-14. PubMed ID: 1899555
[TBL] [Abstract][Full Text] [Related]
12. Comparison of test methods for the lupus anticoagulant: international survey on lupus anticoagulants-I (ISLA-1).
Exner T; Triplett DA; Taberner DA; Howard MA; Harris EN
Thromb Haemost; 1990 Nov; 64(3):478-84. PubMed ID: 2128977
[TBL] [Abstract][Full Text] [Related]
13. Detection and quantitative evaluation of lupus circulating anticoagulant activity.
Rosner E; Pauzner R; Lusky A; Modan M; Many A
Thromb Haemost; 1987 Apr; 57(2):144-7. PubMed ID: 3110995
[TBL] [Abstract][Full Text] [Related]
14. Assays for lupus anticoagulant: the sensitivity of different assays.
Jain A; Dash S; Marwaha N; Deodhar SD; Sehgal S
Med Lab Sci; 1991 Jan; 48(1):31-5. PubMed ID: 1905773
[TBL] [Abstract][Full Text] [Related]
15. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification.
Triplett DA; Barna LK; Unger GA
Thromb Haemost; 1993 Nov; 70(5):787-93. PubMed ID: 8128436
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for appropriate activated partial thromboplastin time reagent selection and utilization.
Fritsma GA; Dembitzer FR; Randhawa A; Marques MB; Van Cott EM; Adcock-Funk D; Peerschke EI
Am J Clin Pathol; 2012 Jun; 137(6):904-8. PubMed ID: 22586049
[TBL] [Abstract][Full Text] [Related]
17. The lupus anticoagulant.
Moriau M; Lavenne-Pardonge E; Col-De Beys C; Lambert M; Coche E
Ann Ital Med Int; 1986 Dec; 1(4):303-6. PubMed ID: 3152786
[No Abstract] [Full Text] [Related]
18. [A study on evaluation of circulating anticoagulant in borderline cases].
Ishii K; Himizu M; Ono F; Yamamoto M; Kawai Y; Watanabe K; Iri H
Rinsho Byori; 1989 Dec; 37(12):1379-84. PubMed ID: 2515324
[TBL] [Abstract][Full Text] [Related]
19. The laboratory diagnosis of lupus anticoagulants.
Lazarchick J; Kizer J
Arch Pathol Lab Med; 1989 Feb; 113(2):177-80. PubMed ID: 2492798
[TBL] [Abstract][Full Text] [Related]
20. Correction of clotting factor "deficiencies" in plasma from patients with lupus-like anticoagulants.
Clyne LP; Honig CL; Dainiak N
Thromb Haemost; 1984 Jul; 51(3):317-20. PubMed ID: 6437003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
